Skip to main content
. Author manuscript; available in PMC: 2020 Jul 10.
Published in final edited form as: Stat Med. 2019 Apr 7;38(15):2868–2882. doi: 10.1002/sim.8157

Table 1.

Evaluating discovery rate of Cτ and Cτ* indices for intermediate disease that can progress or regress. 1000 simulation data sets of 150 subjects were used. 10 candidate predictors are evaluated: 5 correlated and 5 independent of the disease process. Time to progression and first regression are 69% and 34% right-censored, respectively. For Cτ, only disease progression was used. The Cτ* index uses both disease progression and regression events with outcome-specific weights of 1 and 0.75, respectively. Both indices were evaluated at τ = 25. Negative and positive signs for the bias indicates underestimation and overestimation, respectively. ESD is the empirical standard deviation; ASE is the asymptotic standard error; CP is the coverage probability. False discovery rate (FDR) is defined as the number of independent predictors that reject H0 divided by the number of all predictors that reject H0, averaged over 1000 simulation runs. The null hypothesis is H0 : Cτ = 0.5 or H0 : Cτ*= 0.5.

Cτ Cτ*

True Estimate 0.841 0.834
Predictor Bias 0.000 0.000
ESD 0.026 0.018
ASE 0.025 0.018
CP 0.928 0.929
Reject H0 1 1
Correlated Estimate 0.549 0.547
Factors Bias 0.003 0.000
ESD 0.045 0.030
ASE 0.043 0.030
CP 0.940 0.947
Reject H0 0.230 0.356
Independent Estimate 0.500 0.500
Factors Bias 0.000 0.000
ESD 0.045 0.030
ASE 0.044 0.030
Cov 0.940 0.948
Reject H0 0.060 0.052
FDR 0.199 0.126